课题基金 / 基金详情

Reducing ovarian cancer risk by regulating age-associated ovarian fibrosis

Reducing ovarian cancer risk by regulating age-associated ovarian fibrosis
通过调节与年龄相关的卵巢纤维化来降低卵巢癌风险
批准号:
419086
负责人:
Vanderhyden Barbara C
金额:
$49.6万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
未结题
起止时间:
2020-03-01 至 2025-03-01

项目摘要

项目成果

Vanderhyden Barbara C的其他基金

相似基金

相关文献

中文摘要
翻译
对大多数女性来说,患卵巢癌的最大风险因素是每月排卵。口服避孕药可以预防排卵,并可将卵巢癌风险降低35%,但排卵如何增加风险尚不清楚。在试图找到一个解释,你
英文摘要
For most women, the largest risk factor for ovarian cancer is the monthly ovulation. Oral contraceptives prevent ovulation and can reduce ovarian cancer risk by up to 35%, but how ovulation increases risk is not clear. In trying to find an explanation, ou
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Increasing anti-tumoral responses to ovarian cancer using engineered viruses
  • 批准号:
    468827
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.04万
  • 财政年份:
    2022
  • 负责人:
    Vanderhyden Barbara C
  • 依托单位:
2020 Canadian Conference on Ovarian Cancer Research: Intensity Innovation, Improve Impact
  • 批准号:
    404263
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.73万
  • 财政年份:
    2019
  • 负责人:
    Vanderhyden Barbara C
  • 依托单位:
Enhancing ovarian cancer immunogenicity by increasing antitumoral responses using engineered oncolytic vaccines
  • 批准号:
    370624
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.32万
  • 财政年份:
    2017
  • 负责人:
    Vanderhyden Barbara C
  • 依托单位:
Role of ovarian epithelial progenitor cells in ovulatory wound repair
  • 批准号:
    306430
  • 项目类别:
    Operating Grants
  • 资助金额:
    $43.74万
  • 财政年份:
    2014
  • 负责人:
    Vanderhyden Barbara C
  • 依托单位:
海外基金